# Oral CXA-10 in Pulmonary Arterial Hypertension

> **NCT04125745** · PHASE2 · TERMINATED · sponsor: **Gladwin, Mark, MD** · enrollment: 1 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** CXA-10

## Key facts

- **NCT ID:** NCT04125745
- **Lead sponsor:** Gladwin, Mark, MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-31
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** negative study outcome from Complexa's multicenter clinical trial; no safety concerns
- **Last updated:** 2022-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04125745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04125745, "Oral CXA-10 in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04125745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*